APA引文

Thanapirom, K., Suksawatamnuay, S., Sukeepaisarnjareon, W., Tanwandee, T., Charatcharoenwitthaya, P., Thongsawat, S., . . . Komolmit, P. (2018). Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study.

Chicago Style Citation

Thanapirom, Kessarin, et al. Genetic Variation in the Vitamin D Pathway CYP2R1 Gene Predicts Sustained HBeAg Seroconversion in Chronic Hepatitis B Patients Treated With Pegylated Interferon: A Multicenter Study. 2018.

MLA引文

Thanapirom, Kessarin, et al. Genetic Variation in the Vitamin D Pathway CYP2R1 Gene Predicts Sustained HBeAg Seroconversion in Chronic Hepatitis B Patients Treated With Pegylated Interferon: A Multicenter Study. 2018.

警告:這些引文格式不一定是100%准確.